Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
1.
Ter Arkh ; 82(7): 11-9, 2010.
Artigo em Russo | MEDLINE | ID: mdl-20853603

RESUMO

AIM: To evaluate the efficiency of the original ALL-MB-2002 protocol within the multicenter study of treatment of acute lymphoblastic leukemia (ALL) in children. SUBJECTS AND METHODS: A total of 1873 primary patients with ALL aged 1 to 18 years, of whom 1544 patients were enrolled in this study, were notified at 36 clinics of Russia and Belarus from April 15, 2002, to January 1, 2008. RESULTS: With the median observation of 4.12 years, 7-year event-free survival (EFS) was 73 +/- 13%; overall survival (OS) 78 +/- 2%; relapse-free survival 82 +/- 1%. The rates of EFS and OS were equal and amounted to 76 +/- 2 and 80 +/- 2% in the standard-risk group (SRG) and intermediate-risk group (ImRG), respectively. In the high-risk group (HRG) patients, EFS and OS were as high as 30 +/- 6 and 37 +/- 6%, respectively. The frequency of relapses with central nervous system lesion was as much as 4.7% in all the patients, 6-year cumulative risk for isolated neurorecurrences being 2.5% in the SRG patients. Adolescents, patients with the baseline leukocytosis (more than 100 x 10(9)/l), and those with a splenic size of over 4 cm or more from the costal arch margin had substantially worse survival rates. A poor early response to therapy (on induction days 8 and 15) was also associated with its lower efficiency. CONCLUSION: Despite a considerable rise in the number of centers and a slight increase in the intensity of therapy, the results of the new ALL-MB-2002 protocol are as minimum equivalents obtained in the use of the previous ALL-MB-91 protocol. A significant improvement in the overall results of therapy and a reduction in the cumulative risk for isolated neurorecurrences were noted in the ImRG patients.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Adolescente , Fatores Etários , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Criança , Pré-Escolar , Intervalo Livre de Doença , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Humanos , Lactente , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidade , Leucemia-Linfoma Linfoblástico de Células Precursoras/prevenção & controle , Recidiva , Federação Russa
2.
Leukemia ; 22(6): 1144-53, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18368070

RESUMO

Until 1990, the survival of children with acute lymphoblastic leukaemia (ALL) in Russia was below 10%. To establish a protocol feasible under conditions there, ALL-MB 91 was designed to avoid prolonged bone marrow aplasia, thereby reducing needs for extensive supportive care, blood transfusions, long-lasting hospitalization and costs. High-dose therapies were avoided, anthracycline use was limited and CNS radiation therapy only foreseen in high-risk patients (about 30%). This was randomized against a modified BFM protocol. From 1995 to 2002, 834 patients of age up to 18 years were registered in 10 centres and 713 received after central randomization the allocated risk-stratified treatment. After a median follow-up of 7 years, the event-free survival (EFS) was 67+/-3% on ALL-MB 91 (N=358) vs 68+/-3% on ALL-BFM 90m (N=355). The overall survival (OS) was 71+/-3% vs 74+/-2%, respectively. Anaemia, thrombocytopenia, agranulocytosis >10 days and hospitalization (median 35 vs 68 days) were lower on ALL-MB 91 (P<0.01, N=197). While EFS and OS were similar with both protocols, ALL-MB 91 significantly incurred fewer toxicity and resource requirements and, therefore, has been increasingly used across Russia.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Adolescente , Asparaginase/administração & dosagem , Criança , Pré-Escolar , Citarabina/administração & dosagem , Daunorrubicina/administração & dosagem , Estudos de Viabilidade , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Metotrexato/administração & dosagem , Cuidados Paliativos , Prednisona/administração & dosagem , Federação Russa , Resultado do Tratamento , Vincristina/administração & dosagem
3.
Genetika ; 43(9): 1273-6, 2007 Sep.
Artigo em Russo | MEDLINE | ID: mdl-17990527

RESUMO

This study continues the investigation of genetic variation in the populations of native and acclimatized in the Azov-Black Sea basin pilengas from the Sea of Japan. The previous comparison based on allozyme analysis was supplemented by analysis of restriction polymorphism of a mitochondrial DNA fragment containing the cytochrome b gene and the D-loop. Five out of fifteen endonucleases tested detected polymorphic sites. In the samples of native and acclimatized pilengas, five common haplotypes were found; ten and three "population-specific" haplotypes were detected in the Far Eastern and the Azov populations, respectively. The differences in haplotype distributions between these populations were highly significant (P < 0.001). The mtDNA variation was lower in the Azov than in the Far Eastern population (haplotype diversity mu respectively 6.35 +/- 0.27 and 9.14 +/- 0.55), which is in good agreement with the decrease in the number of polymorphic loci and the mean number of alleles per locus, found earlier for allozyme markers in this population. The reasons for these differences in the acclimatized population are discussed.


Assuntos
DNA Mitocondrial/genética , Variação Genética , Smegmamorpha/genética , Aclimatação , Animais , Citocromos b/genética , Haplótipos , Oceanos e Mares , Smegmamorpha/fisiologia
4.
Ter Arkh ; 79(7): 19-26, 2007.
Artigo em Russo | MEDLINE | ID: mdl-17802785

RESUMO

AIM: A comparative analysis of efficacy and toxicity of two chemotherapy regimens: standard German protocol ALL-BFM 90m and less intensive original test protocol ALL-MB 91 in a multicenter trial of acute lymphoblastic leukemia (ALL) in children. MATERIAL AND METHODS: In 1995-2002 a total of 834 patients with newly diagnosed ALL aged 0-18 years were admitted to 10 clinics of Russia. Of them, 713 were randomized in two groups: treatment program ALL-BFM 90m (n = 355) and ALL-MB 91 program (n = 358). RESULTS: In 7-year follow-up median, 10-year event-free survival (EFS) and overall survival (OS) did not differ significantly between the groups and was 67 +/- 3 and 68 +/- 3% (ALL-MB 91) and 74 +/- 2, 71 +/- 3% (ALL-BFM 90m), respectively. Though the rate of isolated recurrences in CNS in patients on the protocol ALL-MB 91 was 2.8%, they developed only in 0.8% patients of the standard risk group. Anemia, thrombocytopenia and agranulocytosis developed less frequently, hospital stay was significantly shorter on the test protocol vs the control one (p < 0.01). CONCLUSION: EFS and OS on the test (ALL-MB 91) and control (ALL-BFM 90m) protocols were equivalent in lower toxicity and cost of therapy.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/economia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Asparaginase/efeitos adversos , Asparaginase/economia , Asparaginase/uso terapêutico , Criança , Pré-Escolar , Ciclofosfamida/efeitos adversos , Ciclofosfamida/economia , Ciclofosfamida/uso terapêutico , Citarabina/efeitos adversos , Citarabina/economia , Citarabina/uso terapêutico , Daunorrubicina/efeitos adversos , Daunorrubicina/economia , Daunorrubicina/uso terapêutico , Feminino , Humanos , Masculino , Mercaptopurina/efeitos adversos , Mercaptopurina/economia , Mercaptopurina/uso terapêutico , Metotrexato/efeitos adversos , Metotrexato/economia , Metotrexato/uso terapêutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidade , Prednisona/efeitos adversos , Prednisona/economia , Prednisona/uso terapêutico , Resultado do Tratamento , Vincristina/efeitos adversos , Vincristina/economia , Vincristina/uso terapêutico
5.
Genetika ; 40(8): 1113-22, 2004 Aug.
Artigo em Russo | MEDLINE | ID: mdl-15523850

RESUMO

The introduction of Far Eastern mullet (pilengas) in the Azov Sea in the 1970s-1980s has resulted in the formation of a self-reproducing commercial population. We have carried out a comparative population-genetic analysis of the mullet from the native (Primorye, the Sea of Japan basin) and the new (The Azov Sea basin) ranges. Genetic characteristics of three Primorye and three Azov local samples were studied using electrophoretic analysis of 15 enzymes encoded by 21 gene loci. In the Azov mullet, the initial heterozygosity characteristic of the donor population was preserved while the genotype and the allele compositions changed; the changes included a 1.9-fold reduction in the percentage of polymorphic loci and 1.5-fold reduction in the mean number of alleles per locus. The genetic differences between the Azov and the Primorye sample groups were highly significant. In the native range, no genetic differentiation among the mullet samples from different areas was found (Gst = 0.42%), whereas in the Azov Sea basin, the samples from spatially isolated populations (ecological groups) exhibited genetic differences (Gst = 1.38). The genetic divergence of the subpopulations and the excess of heterozygotes at some loci in the Azov mullet suggest selection processes that formed genetically divergent groups associated with the areas of different salinity in the new range. The salinity level is assumed to be the most probable factor of local differentiating selection during fast adaptation and naturalization of the introduced mullet.


Assuntos
Adaptação Fisiológica , Genética Populacional , Smegmamorpha/genética , Animais , Heterozigoto
6.
Vopr Onkol ; 48(3): 340-6, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12455359

RESUMO

The report deals with the results of application of an original protocol--the Berlin-Moscow-91 (BM-91)--for the treatment of acute lymphoblastic leukemia (ALL) in children. The researchers' major concern was to improve survival and cut down side-effects incidence as well as to prevent and successfully manage occult neuroleukemia as a potential source of relapse. Patients aged 5 months-15 years received the BM-91 and ALL BFM-90m treatment first at one clinic and later at several centers. Out of 852 children with primary diagnosis of ALL admitted to Russian hematological hospitals (March 2, 1991-November 3, 2000), 687 were included into the study; 329 received the MB-91 protocol. Nine-year recurrence-free survival was 73% while overall survival--80%. Toxic side-effects after L-asparaginase were reported in 27 (7.9%). It is concluded that good results in childhood ALL treatment can be achieved without resorting to high-dosage chemotherapy and radiation in most cases.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Adolescente , Antimetabólitos Antineoplásicos/administração & dosagem , Antineoplásicos/administração & dosagem , Antineoplásicos Hormonais/administração & dosagem , Antineoplásicos Fitogênicos/administração & dosagem , Asparaginase/administração & dosagem , Criança , Pré-Escolar , Citarabina/administração & dosagem , Interpretação Estatística de Dados , Daunorrubicina/administração & dosagem , Dexametasona/administração & dosagem , Feminino , Seguimentos , Humanos , Lactente , Masculino , Mercaptopurina/administração & dosagem , Metotrexato/administração & dosagem , Moscou , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidade , Indução de Remissão , Fatores de Risco , Federação Russa , Análise de Sobrevida , Fatores de Tempo , Vincristina/administração & dosagem
7.
Vopr Onkol ; 48(3): 347-51, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12455360

RESUMO

Prognosis for children treated according to the BFM-90m protocol (Berlin-Frankfurt-Munster Group) for acute lymphoblastic leukemia (ALL) improved significantly as compared with previous modalities. Methotrexate was used in the dose of 1,000 mg/m2, 36 h. The paper presents the 10-year results for this modification. Patients aged 0-15 years were treated at hematological hospitals of Moscow, other Russian towns and in Minsk, Belarus, (July 5, 1990-November 11, 2000). BFM-90m treatment was given to 682 children out of 1,326 with primary diagnosis of ALL; a comparative trial of the MB-91 protocol hed been carried out at the same clinics since 1991. During 10 years, recurrence-free survival was 72% while overall survival--77%. Toxicity of side-effects was tolerable. The BFM-90m treatment showed significantly better results in both countries.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Adolescente , Fatores Etários , Antimetabólitos Antineoplásicos/administração & dosagem , Distribuição de Qui-Quadrado , Criança , Pré-Escolar , Interpretação Estatística de Dados , Feminino , Seguimentos , Humanos , Lactente , Recém-Nascido , Leucovorina/administração & dosagem , Masculino , Metotrexato/administração & dosagem , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidade , Prognóstico , República de Belarus , Fatores de Risco , Federação Russa , Fatores Sexuais , Análise de Sobrevida , Fatores de Tempo
10.
Biull Eksp Biol Med ; 112(12): 607-8, 1991 Dec.
Artigo em Russo | MEDLINE | ID: mdl-1777624

RESUMO

We have investigated the effects of Pro-Met-Asp-Phe-NH2 (PMAP) on insulin and glucagon release from human fetal pancreatic microfragments in vitro. Four batches of precultured microfragments were incubated for 24 hrs in medium containing 5.5 mM glucose, 17 mM glucose, 1 microM PMAP or 1 microM PMAP plus 17 mM glucose. PMAP significantly enhanced both basal and glucose-stimulated insulin release (2.2- and 4.1-fold, respectively). Glucagon secretion was markedly inhibited by glucose (17 mM). PMAP neither affected the basal glucagon release nor potentiated the inhibitory action of glucose on glucagon release. Hence, PMAR selectively regulates insulin production in human fetal islet tissue without affecting glucagon production. Our results suggest that the substances similar or related to PMAP may prove to be of clinical value in drug correction of diabetes mellitus.


Assuntos
Glucagon/metabolismo , Insulina/metabolismo , Pâncreas/efeitos dos fármacos , Tetragastrina/farmacologia , Feto , Humanos , Secreção de Insulina , Técnicas de Cultura de Órgãos , Pâncreas/metabolismo
11.
Biull Eksp Biol Med ; 110(10): 386-9, 1990 Oct.
Artigo em Russo | MEDLINE | ID: mdl-2177669

RESUMO

Administration of Ca-entry blockers with different chemical structure before the braining sessions produced the reduction of memory retention in mice and rats in the one-trial passive avoidance tests. This effect was absent in animals treated immediately after training test. Nootropic drugs piracetam and oxiracetam corrected the retention of memory when injected just after training test. Chronic treatment of rats with increasing doses of the nootropic drugs produced about two-fold tissue-specific elevation in the density of DHP-receptors, associated with L-type Ca-channels in synaptosomal membranes of rat cerebral cortex. Maximal effect was observed in a dose of 10 mg/kg. Diltiazem, administrated in a dose of 10 mg/kg, produced about two-fold decrease in the receptors density measured 24 hrs after the first injection. Oxiracetam (10 mg/kg) completely antagonized the effect of Ca-entry blocker. These data imply that nootropic action of piracetam and oxiracetam is mediated by L-type Ca-channels.


Assuntos
Aprendizagem da Esquiva/efeitos dos fármacos , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/efeitos dos fármacos , Memória/efeitos dos fármacos , Psicotrópicos/farmacologia , Animais , Córtex Cerebral/efeitos dos fármacos , Diltiazem/farmacologia , Masculino , Camundongos , Piracetam/farmacologia , Pirrolidinas/farmacologia , Ratos , Ratos Endogâmicos
12.
Brain Res ; 525(2): 319-21, 1990 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-2174714

RESUMO

Ca2+ entry blockers riodipine, D-cis-diltiazem and verapamil, when administered i.p. to rats at a dose of 10 mg/kg, produced two-fold decreases in the density of 1,4-dihydropyridine (DHP) receptors in rat cerebral cortex, as revealed by Scatchard plot analysis of radioligand binding made 24 h after the first injection. Thereafter, the number of DHP binding sites increased up to the initial level on day 4 of the treatment. The nootropic drug oxiracetam, when injected simultaneously with Ca2+ channel blockers at a dose of 10 mg/kg, prevented this transient decrease in DHP receptor density in brain. These results can explain the opposite modulation of memory retention by calcium antagonists and nootropic drugs that has been observed previously.


Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Córtex Cerebral/metabolismo , Pirrolidinas/farmacologia , Receptores Nicotínicos/metabolismo , Animais , Canais de Cálcio , Córtex Cerebral/efeitos dos fármacos , Diltiazem/farmacologia , Relação Dose-Resposta a Droga , Cinética , Masculino , Nifedipino/análogos & derivados , Nifedipino/farmacologia , Ratos , Ratos Endogâmicos , Receptores Nicotínicos/efeitos dos fármacos , Valores de Referência , Verapamil/farmacologia
13.
Biull Eksp Biol Med ; 108(11): 618-20, 1989 Nov.
Artigo em Russo | MEDLINE | ID: mdl-2633832

RESUMO

Five Hybridoma clones producing monoclonal antibodies (MAT) to bovine nerve growth factor (NGF) were developed. The biological effects of antibodies were studied: the influence of MAT on neurit outgrowth induced by NGF in rat pheochromocytoma PC12 or spinal chicken ganglia was investigated. MAT fell into two groups. Two of them inhibited neurit induction by NGF, three others stimulated this process. The stimulation of the neurit outgrowth by MAT was observed at low concentration of NGF (3 ng/ml of culture medium). Mechanisms of antibodies effects are discussed.


Assuntos
Anticorpos Monoclonais/farmacologia , Diferenciação Celular/efeitos dos fármacos , Fatores de Crescimento Neural/imunologia , Animais , Bovinos , Células Cultivadas , Meios de Cultura , Hibridomas , Camundongos , Camundongos Endogâmicos BALB C , Fatores de Crescimento Neural/farmacologia
14.
Tsitologiia ; 31(3): 312-8, 1989 Mar.
Artigo em Russo | MEDLINE | ID: mdl-2546305

RESUMO

The plasma membrane of human embryonic fibroblasts was shown to contain receptor binding sites for 1,4-dihydropyridine (DHP) Ca2+ entry blockers. In a subconfluent culture grown in serum medium the content of the DHP receptor amounted to 1.2 +/- 0.3 pmol per 10(6) cells. With progression to confluency this value decreased up to 0.28 +/- 0.08 pmol per 10(6) cells. The DHP binding capacity was shown to be affected by the presence of growth factors in culture medium. In a subconfluent culture of serum-deprived cells the content of DHP binding sites increased 1.9 fold, the steady-state level being achieved within 3 days in culture. The serum gradually reversed this process, and the DHP receptor density approached the initial level within 3 days.


Assuntos
Bloqueadores dos Canais de Cálcio , Di-Hidropiridinas/farmacocinética , Fibroblastos/metabolismo , Receptores Nicotínicos/metabolismo , Canais de Cálcio , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Células Cultivadas , Embrião de Mamíferos , Fibroblastos/efeitos dos fármacos , Substâncias de Crescimento/farmacologia , Humanos , Proteínas de Membrana/metabolismo , Ligação Proteica/efeitos dos fármacos , Receptores Nicotínicos/análise , Receptores Nicotínicos/efeitos dos fármacos , Fatores de Tempo , Trítio
16.
FEBS Lett ; 233(2): 352-4, 1988 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-2454846

RESUMO

By using the radioactively labeled 1,4-dihydropyridine (DHP) probe, [3H]PMD, we have demonstrated that cultured human embryonic fibroblasts grown at a low density in Eagle's medium supplemented with serum contain a single class of non-interacting DHP binding sites (Bmax, 1.2 +/- 0.3 pmol/10(6) cells; Kd, 3.9 nM). After inhibition of the DHP receptor biosynthesis by cycloheximide, the number of [3H]PMD binding sites is reduced with a half-time of 12 h, which implies a turnover rate of 30,000 +/- 7500 receptors/h per cell. With progression to confluency, the Bmax value decreased up to 0.28 +/- 0.08 pmol/10(6) cells without significant change in Kd value. When cells were grown at a low density in serum-free conditions, the number of [3H]PMD binding sites gradually increased 1.9-fold within 3 days. Addition of serum reversed this effect with the same time course. These results imply that the DHP-sensitive Ca2+ channels are involved in the control of the proliferation of human embryonic fibroblasts.


Assuntos
Cálcio/metabolismo , Di-Hidropiridinas/metabolismo , Canais Iônicos/metabolismo , Receptores Nicotínicos/metabolismo , Bloqueadores dos Canais de Cálcio/metabolismo , Canais de Cálcio , Embrião de Mamíferos , Fibroblastos/metabolismo , Humanos , Cinética
17.
Biochem Biophys Res Commun ; 132(2): 591-7, 1985 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-2933039

RESUMO

Ca2+-independent protein-modulator (BacM) was found in the culture medium of Staphylococcus aureus. BacM activated calmodulin-dependent cyclic nucleotide phosphodiesterase and Ca2+/Mg2+-ATPase in the same way as calmodulin. BacM was shown to be a proteolytic fragment of the exotoxin secreted by the S. aureus strain under study. The kinetic analyses of the ATPase activation by BacM and CaM were performed. These studies demonstrated that the enzyme molecule contains at least two activator-sensitive sites. Experiments on the ATPase activation by Ca2+ both in the presence and in the absence of BacM and CaM documented that CaM-ATPase and BacM-ATPase complexes can exist at low concentrations of calcium. Analysis of activation curves of ATPase by Ca2+ revealed three Ca2+-binding sites in the enzyme-activator complex.


Assuntos
Proteínas de Bactérias/isolamento & purificação , ATPase de Ca(2+) e Mg(2+)/metabolismo , ATPases Transportadoras de Cálcio/metabolismo , Calmodulina/metabolismo , Staphylococcus aureus/análise , Aminoácidos/análise , Proteínas de Bactérias/metabolismo , Proteínas de Bactérias/farmacologia , Cálcio/farmacologia , Eletroforese em Gel de Poliacrilamida , Ativação Enzimática/efeitos dos fármacos , Ponto Isoelétrico , Cinética , Trifluoperazina/farmacologia
18.
Mol Biol (Mosk) ; 19(1): 248-66, 1985.
Artigo em Russo | MEDLINE | ID: mdl-2984548

RESUMO

The paper surveys the data obtained during the last years in the Laboratory of Regulation of Cellular Activity of the Institute of Molecular Biology. The data mostly concern the enzymes taking part in metabolism and in biological action of the secondary messengers, as well as the mechanisms of regulation of some metabolic pathways in the cultured cells. The results pertinent to the mechanisms of chromatin condensation and based on this genetic control processes are also discussed.


Assuntos
Calmodulina/metabolismo , AMP Cíclico/metabolismo , Hormônios/fisiologia , Proteínas Quinases/metabolismo , 2',5'-Oligoadenilato Sintetase/metabolismo , Regulação Alostérica , Sequência de Aminoácidos , Animais , Encéfalo/metabolismo , Cálcio/metabolismo , Cromatina/metabolismo , Ativação Enzimática/efeitos dos fármacos , Epinefrina/farmacologia , Histonas/metabolismo , Humanos , Técnicas In Vitro , Cinética , Camundongos , Diester Fosfórico Hidrolases/metabolismo , Conformação Proteica , Baço/metabolismo , Teofilina/farmacologia
19.
Vopr Med Khim ; 30(4): 60-4, 1984.
Artigo em Russo | MEDLINE | ID: mdl-6506586

RESUMO

Correlation between a pro-oxidant activity of blood, estimated by means of chemoluminescence in the system H2O2-luminol-blood plasma, and individual sensitivity of rabbits to the effect of oxygen was studied. Alterations in the blood pro-oxidant activity, as shown by treatment of the blood sample with 0.7 MPa of oxygen in vitro, correlated distinctly with the period of convulsions as well as with viability of animals during acute hyperoxia.


Assuntos
Oxigenoterapia Hiperbárica , Oxigênio/toxicidade , Animais , Ceruloplasmina/metabolismo , Feminino , Peróxido de Hidrogênio/sangue , Medições Luminescentes , Masculino , Oxirredução , Coelhos , Convulsões/sangue , Convulsões/induzido quimicamente
20.
Biull Eksp Biol Med ; 98(7): 42-3, 1984 Jul.
Artigo em Russo | MEDLINE | ID: mdl-6466828

RESUMO

The relative effectiveness of radical formation by different concentrations of hemoglobin, hemin and Fe2+ in the reaction with H2O2 evaluated by the intensity of chemiluminescence was studied. Hemoglobin was shown to be remarkably effective at the concentrations close to those in blood plasma. It is suggested that exoerythrocyte hemoglobin and the products of its destruction up to hemin are the most effective prooxidants and potential centers of radical formation in the blood.


Assuntos
Compostos Ferrosos , Heme , Hemina , Hemoglobinas , Peróxido de Hidrogênio , Ferro , Medições Luminescentes , Heme/análogos & derivados
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...